Zn-curc was detected in the glioblastoma tissues, highlighting its capacity to reach the tumor site and affect molecular pathways important for tumor angiogenesis, and impairment of response to therapies such as VEGF, MDR1 and Bcl2. The gene discussed is BCL2; the disease is neoplasm.